Beam Therapeutics BEAM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$414.64M-4.0% | -$398.58M-3.2% | -$386.4M-2.6% | ||
| $22.37M+0.3% | $22.29M+1.0% | $22.07M+0.4% | $21.98M-0.2% | $22.02M+0.4% | ||
| $86.61M-8.1% | $94.24M-9.4% | $104.01M-6.1% | $110.83M-6.1% | $118.06M-2.2% | ||
| -$369.73M-7.1% | -$345.1M-2.0% | -$338.18M+1.9% | -$344.82M+1.9% | -$351.38M-1.2% | ||
| $14.11M-5.6% | $14.95M+5.4% | $14.18M+32.0% | $10.75M+12.3% | $9.57M+7.0% | ||
| —— | —— | —— | -$144.52M-227% | $113.38M-38.7% | ||
| —— | —— | —— | —— | —— | ||
| $101.28M-78.8% | $478.05M-0.3% | $479.61M+0.1% | $479.19M+0.2% | $478.22M+6,082% | ||
| -$239.53M-2,181% | $11.51M— | —— | —— | —— | ||
| -$383.84M-6.6% | -$360.05M-2.2% | -$352.36M+0.9% | -$355.57M+1.5% | -$360.96M-1.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beam Therapeutics generate?
- Beam Therapeutics (BEAM) generated -$369.7M in operating cash flow over the trailing twelve months.
- What is Beam Therapeutics's free cash flow?
- After $14.1M of capital expenditures, Beam Therapeutics's free cash flow was -$383.8M over the trailing twelve months, down 6.3% year over year.
- Where does Beam Therapeutics's cash flow data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
